JM9

Known as: JM-9 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-1992
01219821992

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Qualitative and quantitative ultrastructural effects of the platinum compounds cisplatin (Platinol), carboplatin (JM8), and… (More)
Is this relevant?
1989
1989
Cisplatin is a backbone of any combination chemotherapy currently in use for the treatment for nonseminomatous germ cell tumors… (More)
Is this relevant?
1988
1988
Urinary protein and enzyme excretion was measured in 33 patients with solid tumours receiving chemotherapy with the cis-platinum… (More)
  • table I
  • figure 2
  • table 2
  • figure 3
  • figure 4
Is this relevant?
1987
1987
The comparative antitumour activity of cisplatin, JM8 and JM9 was tested using a panel of different heterotransplanted human… (More)
Is this relevant?
1986
1986
Cis-diamminedichloroplatinum (cisplatin), a divalent platinum compound and cell-cycle nonspecific chemotherapeutic agent… (More)
Is this relevant?
1986
1986
We evaluated the cytotoxic and DNA cross-linking (CL) ability of four second generation platinum coordination complexes (TNO-6… (More)
Is this relevant?
1986
1986
This report describes the release of methotrexate and cis-platinum analogues JM8 and JM9 from phase transition liposomes. Large… (More)
Is this relevant?
1985
1985
Thirty-nine patients with advanced solid tumors, including 28 with ovarian cancer, were entered in a phase I-II trial of a new… (More)
Is this relevant?
1985
1985
The cytotoxic activity of cis-DDP and four second generation platinum coordination complexes (TNO-6; JM-82; JM-8; and JM-9) was… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1982
1982
Bis(isopropylamine)-trans-dihydroxy-cis-dichloroplatinum(IV) (CHIP or JM-9), a derivative of Cisplatin, was found to have DNA… (More)
Is this relevant?